Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Clovis Oncology Inc CLVSQ

Healthcare Biotechnology
Clovis Oncology, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe and additional international markets. Its segments include U.S. and ex-U.S. Its product, Rubraca, is an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP) marketed in the United States for two indications... see more

Recent & Breaking News (PINL:CLVSQ)

Hagens Berman Reminds Clovis Oncology, Inc. (NASDAQ:CLVS) Investors With Losses Over $50,000 of January 19, 2016 Lead Plaintiff Deadline

GlobeNewswire December 28, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Clovis Oncology, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - CLVS

GlobeNewswire December 23, 2015

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Clovis Oncology, Inc. - CLVS

GlobeNewswire December 22, 2015

SECURITIES FRAUD REMINDER: The Law Firm of Andrews & Springer LLC Reminds Clovis Oncology, Inc. Shareholders of Important January 19, 2016 Deadline in the Class Action- CLVS

GlobeNewswire December 21, 2015

INVESTOR ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving Clovis Oncology, Inc. and a Lead Plaintiff Deadline of January 18, 2016 - CLVS

GlobeNewswire December 18, 2015

Clovis Oncology Investor Alert: Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against Clovis Oncology, Inc. - CLVS

Accesswire December 16, 2015

CLVS Investors: GPM Reminds Investors Of The Deadline In The Securities Class Action On Behalf Of Clovis Oncology, Inc. Investors

Business Wire December 16, 2015

Clovis Oncology Receives Notification of PDUFA Extension for Rociletinib

Business Wire December 15, 2015

SHAREHOLDER ALERT:  Pomerantz Law Firm Announces the Filing of a Class Action Against Clovis Oncology, Inc. and Certain Officers - CLVS

GlobeNewswire December 14, 2015

DEADLINE ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Clovis Oncology, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

Business Wire December 13, 2015

Investor Deadline Alert: Law Offices of Howard G. Smith Reminds Clovis Oncology, Inc. Investors of Upcoming Lead Plaintiff Deadline

Business Wire December 11, 2015

Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Clovis Oncology, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit

Business Wire December 10, 2015

Levi & Korsinsky, LLP Reminds Clovis Oncology, Inc. Shareholders of Filing of Class Action Lawsuit and Lead Plaintiff Deadline of January 18, 2016 - CLVS

GlobeNewswire December 9, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Clovis Oncology, Inc. - CLVS

PR Newswire December 8, 2015

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Clovis Oncology, Inc. And Encourages Investors To Contact The Firm Before The Deadline

Business Wire December 8, 2015

Hagens Berman Alerts Investors with Losses Over $50,000 in Clovis Oncology, Inc. (NYSE: CLVS) of January 19, 2016 Lead Plaintiff Deadline

GlobeNewswire December 8, 2015

Lawsuit for Investors in Shares of Clovis Oncology Inc (NASDAQ:CLVS) Announced by Shareholders Foundation

GlobeNewswire December 7, 2015

SECURITIES FRAUD REMINDER: The Law Firm of Andrews & Springer LLC Reminds Clovis Oncology, Inc. Shareholders of Important January 19, 2016 Deadline in the Class Action - CLVS

GlobeNewswire December 7, 2015

SHAREHOLDER REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit Against Clovis Oncology, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire December 4, 2015

CLVS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Clovis Oncology, Inc.

Business Wire December 4, 2015